Acerus Pharms Drug Patent Portfolio
Acerus Pharms owns 1 orange book drug protected by 6 US patents Given below is the list of Acerus Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11419914 | Safe desmopressin administration | 15 Jun, 2030 | Active |
| US12090190 | Safe desmopressin administration | 15 Jun, 2030 | Active |
| US9539302 | Safe desmopressin administration | 15 Jun, 2030 | Active |
| US7799761 | Pharmaceutical compositions including low dosages of desmopressin | 26 Sep, 2024 | Expired |
| US7405203 | Pharmaceutical compositions including low dosages of desmopressin | 06 May, 2023 | Expired |
| US7579321 | Pharmaceutical compositions including low dosages of desmopressin | 06 May, 2023 | Expired |
Latest Legal Activities on Acerus Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Acerus Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Jul, 2024 | US9539302 |
|
Recordation of Patent Grant Mailed
Critical
| 23 Aug, 2022 | US11419914 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Aug, 2022 | US11419914 |
|
Email Notification
Critical
| 04 Aug, 2022 | US11419914 |
|
Issue Notification Mailed
Critical
| 03 Aug, 2022 | US11419914 |
| Mailing Corrected Notice of Allowability | 15 Jul, 2022 | US11419914 |
|
Email Notification
Critical
| 15 Jul, 2022 | US11419914 |
| Corrected Notice of Allowability | 12 Jul, 2022 | US11419914 |
|
Pubs Case Remand to TC
Critical
| 11 Jul, 2022 | US11419914 |
| Dispatch to FDC | 06 Jul, 2022 | US11419914 |
|
Email Notification
Critical
| 05 Jul, 2022 | US11419914 |
| Mailing Corrected Notice of Allowability | 05 Jul, 2022 | US11419914 |
|
Mail Notice of Allowance
Critical
| 30 Jun, 2022 | US11419914 |
|
Email Notification
Critical
| 30 Jun, 2022 | US11419914 |
|
Issue Fee Payment Received
Critical
| 30 Jun, 2022 | US11419914 |
Acerus Pharms's Family Patents
Acerus Pharms Drug List
Given below is the complete list of Acerus Pharms's drugs and the patents protecting them.
1. Noctiva
Noctiva is protected by 6 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11419914 | Safe desmopressin administration |
15 Jun, 2030
(5 years from now)
| Active |
| US12090190 | Safe desmopressin administration |
15 Jun, 2030
(5 years from now)
| Active |
| US9539302 | Safe desmopressin administration |
15 Jun, 2030
(5 years from now)
| Active |
| US7799761 | Pharmaceutical compositions including low dosages of desmopressin |
26 Sep, 2024
(3 months ago)
| Expired |
| US7405203 | Pharmaceutical compositions including low dosages of desmopressin |
06 May, 2023
(1 year, 8 months ago)
| Expired |
| US7579321 | Pharmaceutical compositions including low dosages of desmopressin |
06 May, 2023
(1 year, 8 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Noctiva's drug page